Showing results (581-590 of 829) with videos related to
Sort By:
Pageof 83
Journal of Clinical Medicine|November 13, 2021
Risk Assessment and Clinical Management of Children and Adolescents with Heterozygous Familial Hypercholesterolaemia. A Position Paper of the Associations of Preventive Pediatrics of Serbia, Mighty Medic and International Lipid Expert PanelBojko Bjelakovic, Claudia Stefanutti, Željko Reiner, et al.Atherosclerosis|October 2, 2018
Knowledge, awareness and practice regarding familial hypercholesterolaemia among primary care physicians in Malaysia: The importance of professional trainingAhmad Baihaqi Azraii, Anis Safura Ramli, Zaliha Ismail, et al.Diabetes|February 28, 2003
Differential regulation of lipoprotein kinetics by atorvastatin and fenofibrate in subjects with the metabolic syndromeGerald F Watts, P Hugh R Barrett, Juying Ji, et al.The American Journal of Clinical Nutrition|October 12, 2021
The effect of vitamin K1 on arterial calcification activity in subjects with diabetes mellitus: a post hoc analysis of a double-blind, randomized, placebo-controlled trialJamie W Bellinge, Roslyn J Francis, Sing C Lee, et al.Clinical Endocrinology|June 22, 2010
The effect of fenofibrate on HDL cholesterol and HDL particle concentration in postmenopausal women on tibolone therapyB G A Stuckey, P H R Barrett, J M Wagner, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 8, 1999
Selective diapedesis of Th1 cells induced by endothelial cell RANTEST Kawai, M Seki, K Hiromatsu, et al.JAMA Cardiology|April 7, 2024
Plozasiran (ARO-APOC3) for Severe Hypertriglyceridemia: The SHASTA-2 Randomized Clinical TrialDaniel Gaudet, Denes Pall, Gerald F Watts, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|July 19, 2020
Coronary artery disease and the risk-associated LPA variants, rs3798220 and rs10455872, in patients with suspected familial hypercholesterolaemiaMichael M Page, Katrina L Ellis, Jing Pang, et al.Circulation|September 8, 2017
Low-Density Lipoprotein Cholesterol Lowering for the Primary Prevention of Cardiovascular Disease Among Men With Primary Elevations of Low-Density Lipoprotein Cholesterol Levels of 190 mg/dL or Above: Analyses From the WOSCOPS (West of Scotland Coronary Prevention Study) 5-Year Randomized Trial and 20-Year Observational Follow-UpAntonio J Vallejo-Vaz, Michele Robertson, Alberico L Catapano, et al.Journal of Clinical Lipidology|September 10, 2015
Frequency of familial hypercholesterolemia in patients with early-onset coronary artery disease admitted to a coronary care unitJing Pang, Elissa B Poulter, Damon A Bell, et al.Pageof 83